| 诺和锐30治疗2型糖尿病疗效观察 |
| |
| 引用本文： | 李洁冰,麦伟华,叶建红. 诺和锐30治疗2型糖尿病疗效观察[J]. 中国医药导报, 2010, 7(20): 64-65 |
| |
| 作者姓名： | 李洁冰 麦伟华 叶建红 |
| |
| 作者单位： | 1. 广东省鹤山市中医院,广东鹤山,529700
2. 广东省佛山市中医院,广东佛山,528000 |
| |
| 基金项目： | 佛山市科技公关立项课题 |
| |
| 摘 要： | 目的：探讨诺和锐30治疗2型糖尿病（T2DM）的有效性和安全性。方法：将80例2型糖尿病患者随机分成诺和锐30治疗组和诺和灵30R对照组,每组各40例,治疗12周,观察治疗前后患者的空腹血糖（FPG）,餐后2h血糖（2hPG）,糖化血红蛋白（HbA1c）,低血糖发生率。结果：治疗12周后,诺和锐30治疗组的HbA_（1c）、餐后2h血糖控制明显优于诺和灵30R组,诺和锐30组的低血糖发生率明显低于诺和灵30R组（P〈0.05）。结论：诺和锐30治疗2型糖尿病可较好控制餐后血糖,而且安全性高,依从性好。
|
| 关 键 词： | 2型糖尿病 诺和锐30 糖化血红蛋白 低血糖 |
Therapeutic effects of Novorapid 30 on treatment of patients with type 2 diabetes mellitus |
| |
| LI Jiebing,MAI Weihua,YE Jianhong. Therapeutic effects of Novorapid 30 on treatment of patients with type 2 diabetes mellitus[J]. China Medical Herald, 2010, 7(20): 64-65 |
| |
| Authors: | LI Jiebing MAI Weihua YE Jianhong |
| |
| Affiliation: | 1.Heshan Hospital of TCM,Heshan 529700,China;2.Foshan Hospital of TCM,Foshan 528000,China) |
| |
| Abstract: | Objective：To investigate the therapeutic effects and safety of Novorapid 30 on treatment of patients with type 2 diabetes mellitus.Methods：80 patients aged from 35 to 65 years with type 2 diabetes mellitus were divided into two groups at random.One group was treatment group treated by Novorapid 30 and another was control group treated by No volin 30R.Before and after treatment,fasting plasma glucose（FPG）,2 h plasma glucose（2 hPG）,glycosylated hemoglobin （HbA1c） and incidence of hypoglycemia were observed.Results：After 12 weeks treatment,HbA1c,2 hPG and the incidence of hypoglycemia in treatment group were significantly lower than that in control group（all P0.05）.Conclusion：Compared with Novolin 30R,Novorapid 30 is better in lowering postprandial blood glucose,safety and compliance. |
| |
| Keywords: | Type 2 diabetes mellitus Novorapid 30 HbA1c Hypoglycemia |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
